NYSE:QGEN Qiagen (QGEN) Stock Price, News & Analysis $51.80 +0.57 (+1.10%) Closing price 07/25/2025 03:59 PM EasternExtended Trading$51.79 -0.01 (-0.01%) As of 07/25/2025 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Qiagen Stock (NYSE:QGEN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Qiagen alerts:Sign Up Key Stats Today's Range$51.07▼$51.8850-Day Range$42.07▼$51.8052-Week Range$37.63▼$51.88Volume1.22 million shsAverage Volume1.47 million shsMarket Capitalization$11.51 billionP/E Ratio129.86Dividend Yield0.48%Price Target$49.40Consensus RatingHold Company Overview QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands. Read More Qiagen Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks74th Percentile Overall ScoreQGEN MarketRank™: Qiagen scored higher than 74% of companies evaluated by MarketBeat, and ranked 287th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingHold Consensus RatingQiagen has received a consensus rating of Hold. The company's average rating score is 2.30, and is based on 3 buy ratings, 7 hold ratings, and no sell ratings.Amount of Analyst CoverageQiagen has only been the subject of 2 research reports in the past 90 days.Read more about Qiagen's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth8.85% Earnings GrowthEarnings for Qiagen are expected to grow by 8.85% in the coming year, from $2.26 to $2.46 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Qiagen is 129.86, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 27.04.Price to Earnings Ratio vs. SectorThe P/E ratio of Qiagen is 129.86, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.41.Price to Earnings Growth RatioQiagen has a PEG Ratio of 2.63. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioQiagen has a P/B Ratio of 3.23. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Qiagen's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.51% of the float of Qiagen has been sold short.Short Interest Ratio / Days to CoverQiagen has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Qiagen has recently decreased by 4.60%, indicating that investor sentiment is improving. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldQiagen has a dividend yield of 0.48%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthQiagen does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Qiagen is 62.50%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Qiagen will have a dividend payout ratio of 10.16% next year. This indicates that Qiagen will be able to sustain or increase its dividend.Read more about Qiagen's dividend. Sustainability and ESG4.5 / 5Environmental Score-0.83 Percentage of Shares Shorted2.51% of the float of Qiagen has been sold short.Short Interest Ratio / Days to CoverQiagen has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Qiagen has recently decreased by 4.60%, indicating that investor sentiment is improving. News and Social Media2.2 / 5News Sentiment0.94 News SentimentQiagen has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.09 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Qiagen this week, compared to 8 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Qiagen insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 9.00% of the stock of Qiagen is held by insiders.Percentage Held by Institutions70.00% of the stock of Qiagen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Qiagen's insider trading history. Receive QGEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Qiagen and its competitors with MarketBeat's FREE daily newsletter. Email Address QGEN Stock News HeadlinesQiagen N.V.'s (NYSE:QGEN) high institutional ownership speaks for itself as stock continues to impress, up 4.3% over last weekJuly 25 at 3:38 PM | finance.yahoo.comQIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read PanelsJuly 22, 2025 | businesswire.comElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.July 27 at 2:00 AM | Brownstone Research (Ad)QIAGEN N.V. to Release Results for Q2 2025 and Hold WebcastJuly 8, 2025 | businesswire.comQiagen Teams With Gencurix to Expand Digital PCR Cancer AssaysJuly 3, 2025 | msn.comQiagen N.V. (QGEN) Stock Price, Quote, News & Analysis - Seeking AlphaJune 27, 2025 | seekingalpha.comHere's Why Qiagen (QGEN) is a Strong Value Stock - NasdaqJune 26, 2025 | nasdaq.comQIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory BoardJune 26, 2025 | businesswire.comSee More Headlines QGEN Stock Analysis - Frequently Asked Questions How have QGEN shares performed this year? Qiagen's stock was trading at $43.2931 at the beginning of the year. Since then, QGEN shares have increased by 19.6% and is now trading at $51.7950. How were Qiagen's earnings last quarter? Qiagen N.V. (NYSE:QGEN) released its quarterly earnings data on Wednesday, May, 7th. The company reported $0.55 earnings per share for the quarter, topping analysts' consensus estimates of $0.50 by $0.05. The business's quarterly revenue was up 5.2% compared to the same quarter last year. Read the conference call transcript. When did Qiagen's stock split? Qiagen shares split on Wednesday, January 29th 2025.The 36-35 split was announced on Wednesday, January 22nd 2025. The newly created shares were distributed to shareholders after the closing bell on Tuesday, January 28th 2025. An investor that had 100 shares of stock prior to the split would have 103 shares after the split. Who are Qiagen's major shareholders? Top institutional shareholders of Qiagen include Allspring Global Investments Holdings LLC (1.23%), Public Employees Retirement System of Ohio (0.10%), Banque Pictet & Cie SA (0.04%) and US Bancorp DE (0.03%). How do I buy shares of Qiagen? Shares of QGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Qiagen own? Based on aggregate information from My MarketBeat watchlists, some other companies that Qiagen investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Netflix (NFLX), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM) and PayPal (PYPL). Company Calendar Last Earnings5/07/2025Ex-Dividend for 7/10 Dividend7/02/2025Record date for 7/10 Dividend7/03/2025Dividend Payable7/10/2025Today7/27/2025Next Earnings (Estimated)8/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNYSE:QGEN CIK1015820 Webwww.qiagen.com Phone(177) 355-6600Fax31-77-355-6658Employees5,765Year FoundedN/APrice Target and Rating Average Price Target for Qiagen$49.40 High Price Target$55.00 Low Price Target$43.00 Potential Upside/Downside-4.6%Consensus RatingHold Rating Score (0-4)2.30 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)$0.40 Trailing P/E Ratio129.86 Forward P/E Ratio22.92 P/E Growth2.63Net Income$83.59 million Net Margins4.68% Pretax Margin6.91% Return on Equity14.61% Return on Assets8.80% Debt Debt-to-Equity Ratio0.40 Current Ratio3.37 Quick Ratio2.83 Sales & Book Value Annual Sales$1.98 billion Price / Sales5.82 Cash Flow$3.21 per share Price / Cash Flow16.16 Book Value$16.05 per share Price / Book3.23Miscellaneous Outstanding Shares222,290,000Free Float202,285,000Market Cap$11.51 billion OptionableOptionable Beta0.68 10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NYSE:QGEN) was last updated on 7/27/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredThe big winner of Crypto week?It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption. With Bit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qiagen N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qiagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.